ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Cimicifuga Heracleifolia Rhizome Extract

Also known as: Cimicifuga heracleifolia, Bugbane, Black Cohosh, Heracleifolia Bugbane, *Cimicifuga heracleifolia* Kom.

Overview

*Cimicifuga heracleifolia* is a medicinal plant known for its rhizome, which is rich in bioactive compounds, particularly triterpenoids and cinnamic acid derivatives. Traditionally used in Asian medicine, it exhibits anti-inflammatory, antipyretic, and analgesic properties. Recent research indicates its potential in alleviating menopausal symptoms, although it is not equivalent to *Cimicifuga racemosa*. The extract contains over 100 identified compounds, with triterpene glycosides being its primary bioactive components. Current research on this herb indicates moderate maturity, with ongoing studies to clarify its pharmacological effects and clinical applications.

Benefits

Evidence suggests that *Cimicifuga heracleifolia* possesses notable anti-inflammatory and immunomodulatory effects, particularly via the action of cimigenoside. It may offer relief for menopausal symptoms, making it a potential treatment option for postmenopausal women experiencing issues like hot flashes. While current findings indicate promising effects, studies have not provided specific quantification of these effects, warranting further rigorous investigation to solidify its efficacy and establish treatment protocols.

How it works

The primary biological mechanism of *Cimicifuga heracleifolia* involves anti-inflammatory pathways, achieved through suppression of inflammatory cytokines and chemokines like CXCL2 and CXCL10. It interacts with the immune system, which may influence respiratory and reproductive health due to its modulation of immune responses. Triterpene glycosides are the key components contributing to its bioactive effects, highlighting their significant role in its overall pharmacological profile.

Side effects

Generally recognized as safe when used correctly, *Cimicifuga heracleifolia* may cause gastrointestinal upsets in some individuals. While common side effects are not well-documented, rare allergic reactions could occur. There is a potential for interactions with drugs that affect the immune system or blood clotting. Caution is warranted for pregnant or breastfeeding individuals due to insufficient safety data, as well as those with autoimmune diseases or on immunosuppressive therapy.

Dosage

No established minimum effective dose exists, and traditional uses do not provide standardized dosing guidelines. Optimal dosages remain undetermined, necessitating caution to prevent excessive intake. The form of administration, typically ethanolic extracts, may influence efficacy, with noted bioavailability of triterpene glycosides suggesting oral routes could be effective. Further research is needed to elucidate precise therapeutic dosages and timing considerations.

FAQs

Can I use *Cimicifuga heracleifolia* if I'm on other medications?

Consulting a healthcare provider is essential before use, particularly if you are taking immunosuppressants or anticoagulants.

Is it safe to use during pregnancy?

Due to a lack of safety data, it is advised to avoid use during pregnancy and breastfeeding.

What results can I expect from using it?

Benefits may include relief from inflammation and menopausal symptoms; however, responses can vary significantly among individuals.

How does it compare to *Cimicifuga racemosa*?

While *Cimicifuga heracleifolia* shares therapeutic similarities, it is distinct and not equivalent to *Cimicifuga racemosa*.

What dosage should I take?

There is no standardized dosage; it is best to follow traditional recommendations or consult with a healthcare provider.

Research Sources

  • https://www.researchgate.net/publication/380422520_Traditional_uses_phytochemistry_pharmacology_quality_control_and_clinical_studies_of_Cimicifugae_Rhizoma_a_comprehensive_review – This comprehensive review discusses the traditional uses and pharmacological properties of *Cimicifugae Rhizoma*, including its bioactive constituents and therapeutic potentials, although highlighting the need for more robust clinical studies.
  • https://pubmed.ncbi.nlm.nih.gov/33242624/ – This study investigates the immunomodulatory effects of compounds found in *Cimicifuga heracleifolia*, noting promising findings relating to its anti-inflammatory properties, albeit in non-human models.
  • https://www.semanticscholar.org/paper/Effects-of-Cimicifugae-Rhizoma-on-the-osteogenic-of-Lee-Kim/e79223b4e07773a0bd32c24c9f2eb8705abd3b72 – This paper explores the osteogenic effects of *Cimicifugae rhizoma*, which suggests the therapeutic applications of its compounds, underscoring its multifaceted benefits.
  • https://pubmed.ncbi.nlm.nih.gov/17073639/ – The research outlines the pharmacological similarities between *Cimicifuga heracleifolia* and *Cimicifuga racemosa*, providing preliminary evidence for their comparable efficacy in addressing menopausal symptoms.
  • https://www.researchgate.net/publication/334099876_Cimicifuga_heracleifolia_is_therapeutically_similar_to_black_cohosh_in_relieving_menopausal_symptoms_evidence_from_pharmacological_and_metabolomics_studies – This investigation presents evidence that *Cimicifuga heracleifolia* can relieve menopausal symptoms similarly to *Cimicifuga racemosa*, though it calls for more comparative studies to validate these findings.